Inactive systemic lupus erythematosus is associated with a normal stimulated TH1/TH2 cytokine secretory pattern

Cytokine

Volumn 12, Issue 9, 2000, Pages 1405-1408

  Amit, Mirit ^a   Mor, Anat ^a   Weissgarten, Joshua ^a   Rosenberg, Rosalia ^a   Ramot, Yoram ^a   Wysenbeek, Arjeh J ^a   Rapoport, Micha J ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cytokines; Lupus; Th1; Th2

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; AGE; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL;

EID: 0033802521     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2000.0724     Document Type: Article

References (15)

1. T lymphocytes, NK cells and cytokines in systemic lupus erythematosus
2. Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma
3. Decreased production of and response to Interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus
4. Spontaneous production of Interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus
5. Decreased production of Interleukin-12 and other Th1-type cytokines in patients with systemic lupus erythematosus
6. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of Interleukin-10: Interferon-γ secreting cells in the peripheral blood
7. Interplay between Interleukin-2 and Interleukin-4 in human thymocyte differentiation: Antagonism or synergism
8. Interleukin-4 inhibits Interleukin-2 receptor expression and Interleukin-2 dependent proliferation of human T cells
9. Recombinant Interleukin-4 promotes the growth of human T cells
10. Decreased secretion of Th2 cytokines precedes upregulated and delayed secretion of Th1 cytokines in activated peripheral blood mononuclear cells from patients with insulin-dependent diabetes mellitus
11. The 1982 revised criteria for the classification of systemic lupus erythematosus
12. Derivation of the SLEDAI: A disease activity index for lupus erythematosus patients
13. Glucocorticoid therapy for immune mediated diseases: Basic and clinical correlates
14. Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin-6 and interferon-gamma production by peripheral blood mononuclear cells